Castro Valley, CA, United States of America

Arkadij M Elizarov


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arkadij M Elizarov: Innovator in Chroman Derivatives

Introduction

Arkadij M Elizarov is a notable inventor based in Castro Valley, California. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on chroman derivatives. His research focuses on developing compounds that can address various medical conditions.

Latest Patents

Elizarov holds a patent for novel chroman derivatives, which includes stereoisomers and pharmaceutically acceptable salts of a specific formula. These compounds are designed to be effective in treating disorders mediated by lipoxygenase, including immune diseases, respiratory diseases, and cardiovascular diseases. Additionally, they show promise in the treatment of neurodegenerative and mitochondrial disorders. The patent also highlights their utility in the manufacture of pharmaceutical formulations aimed at these conditions.

Career Highlights

Elizarov is associated with Edison Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work has the potential to impact the pharmaceutical industry significantly, particularly in the treatment of complex diseases.

Collaborations

Some of his notable coworkers include Bing Wang and Gail Walkinshaw, who contribute to the collaborative efforts at Edison Pharmaceuticals, Inc. Their combined expertise enhances the research environment and fosters innovation.

Conclusion

Arkadij M Elizarov's contributions to the field of pharmaceuticals through his patent on chroman derivatives exemplify the importance of innovation in addressing critical health issues. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…